CAS ID: | 2609-46-3 |
Molecular Formula: | C6H8ClN7O |
Molecular Weight: | 229.6 g/mol |
Monoisotopic Mass: | 229.0479 g/mol |
Class: | Small Molecule |
Natural Product: | No |
Other Names: | BERKAMIL | AMILORIDE HYDROCHLORIDE | Amiloride | AMILAMONT | AMIPRAMIDINE | Hydro-Ride | AMORIDE | MIDAMOR | Midamor | AMILOSPARE 5 |
Analysis: | Drug repositioning mechanism analysis |
Reference Record 1
PubMed ID | 19633071 | Target ID | |
Uniprot ID | Name | ||
Model | vitro,human,mice | Fibrosis Disease | Cystic fibrosis |
Process I | |||
Process II | |||
Process III | |||
Mechanism |
Reference Record 2
PubMed ID | 25371970 | Target ID | |
Uniprot ID | Name | ||
Model | vitro,rabbit | Fibrosis Disease | Scar |
Process I | |||
Process II | |||
Process III | |||
Mechanism |
Trial Record 1
ClinicalTrial ID | NCT00274391 | Disease | Cystic fibrosis |
Phase | Phase 2 | Status | Completed |
First Received | January 10, 2006 | Last Verified | January 10, 2006 |
Sponsor | University of North Carolina |
Trial Record 2
ClinicalTrial ID | NCT00547053 | Disease | Cystic fibrosis |
Phase | Phase 1 | Status | Completed |
First Received | October 19, 2007 | Last Verified | May 13, 2011 |
Sponsor | Boston Children’s Hospital |
Trial Record 3
ClinicalTrial ID | NCT00004705 | Disease | Cystic fibrosis |
Phase | Not Applicable | Status | Completed |
First Received | February 25, 2000 | Last Verified | March 25, 2015 |
Sponsor | FDA Office of Orphan Products Development |